E. coli |
|
DH5α |
F′ φ80dlacZΔM15 endA1 recA1 gyrA96 thi-1 hsdR17(rK− mK+) supE44 relA1 deoR Δ(lacZYA-argF)U169 |
9 |
InvαF′ |
F′ endA1 recA1 hsdR17(rK− mK+) supE44 thi-1 gyrA96 relA1 φ80lacZΔM15 Δ(lacZYA-argF)U169 |
Invitrogen |
N. europaea |
|
ATCC 19178 |
|
American Type Culture Collection |
A141 |
Insertion of lacZ/kan into the BamHI site of amoA1
|
This study |
A142 |
Insertion of lacZ/kan into the BamHI site of amoA2
|
This study |
A1 |
Insertion of kan into the BamHI site of amoA1
|
This study |
A2 |
Insertion of kan into the BamHI site of amoA2
|
This study |
Plasmids |
|
pNHA10 |
842-bp PCR fragment containing most of amoA cloned into pCRII vector |
This study |
pNHA11 |
pNHA10 with a mutation in amoA at position 715 (24), creating a BamHI site |
This study |
pNHA12 |
amoA insert cut out of pNHA11 with EcoRI and cloned into EcoRI site of pRL139 |
This study |
pNHA14 |
lacZ/kan fragment from pKOK6.1 inserted into BamHI site of pNHA12 |
This study |
pNHA15 |
kan from pUC4 pKSAC inserted into BamHI site of pNHA12 |
This study |
pUC4 KSAC |
Plasmid containing the kan cassette from Tn903
|
Pharmacia |
pKOK6.1 |
Plasmid containing a promoterless lacZ and kan with its own promoter |
20 |
pCRII |
TA PCR cloning vector (Kanr AmprlacZa f1ori ColE1 ori) |
Invitrogen |
pRL139 |
pUC19 with a symmetrical multiple cloning site |
5 |